general electric said obtained its rights experimental technique for analyzing blood samples detect disease antibodies general electric said bioreactor will attempt develop test market kits from advances made general electric general electric said granted rights bioreactor because innovation first announced 1972 did not fit into company long range product plans exchange for patent said will receive unspecified interest company reuter 